The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability
Abstract
OBJECTIVES: ABCB1 (multidrug resistance 1 polypeptide, MDR1, Pgp) is a multispecific efflux transporter of drugs and xenobiotics. Among numerous polymorphisms in human ABCB1, the synonymous SNP 3435C > T has been associated with decreased mRNA and protein levels, via unknown mechanisms. METHODS: To search for cis-acting polymorphism affecting transcription or mRNA processing, we used 3435C > T as a marker single nucleotide polymorphism (SNP), for measuring differences in allelic mRNA expression. Ratios of allelic abundance in genomic DNA and mRNA (after conversion to cDNA) were measured quantitatively with a primer extension assay, in human liver samples. RESULTS: mRNA expression of the 3435C allele was significantly higher than that of the 3435T allele (3435C/3435T ratios ranging from 1.06-1.61). Cotransfection of equal amounts of ABCB1 expression plasmids containing 3435C or 3435T also revealed higher 3435C mRNA expression. Increasing 3435C/3435T ratios after cessation of transcription indicated that the 3435C > T substitution decreases mRNA stability. 3435C > T is in strong linkage disequilibrium with two other coding SNPs (1236C > T and 2677G > T) forming two abundant haplotypes (ABCB1*1 and ABCB1*13). Transfection of all possible combinations of these three SNPs demonstrated that only 3435T is associated with lower mRNA levels. Calculations of mRNA folding, using Mfold, suggested an effect on mRNA secondary structure. CONCLUSIONS: the abundant 3435C > T SNP appears to be a main factor in allelic variation of ABCB1 mRNA expression in the liver, by changing mRNA stability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mfold web server for nucleic acid folding and hybridization prediction
Zuker, M. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg595 · Cited by 13,404
Hoffmeyer, S., Burk, O., von Richter, O., Arnold, H. P., Brockmöller, J., Johne, A., Cascorbi, I., Gerloff, T., Roots, I., Eichelbaum, M., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3473 · Cited by 2,365
Identification of functionally variant MDR1 alleles among European Americans and African Americans
Kim, R. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.117412 · Cited by 1,009
Duan, J. (2003) · Human Molecular Genetics · doi:10.1093/hmg/12.3.205 · Cited by 930
Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance
Marzolini, C. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.09.012 · Cited by 895
Siddiqui, A., Kerb, R., Weale, M. E., Brinkmann, U., Smith, A., Goldstein, D. B., Wood, N. W., & Sisodiya, S. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021986 · Cited by 665
Fellay, J., Marzolini, C., Meaden, E. R., Back, D. J., Buclin, T., Chave, J.-P., Decosterd, L. A., Furrer, H., Opravil, M., Pantaleo, G., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07276-8 · Cited by 658
P-glycoprotein and multidrug resistance
Gottesman, M. M., Pastan, I., & Ambudkar, S. V. (1996) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(96)80091-8 · Cited by 560
Kroetz, D. L., Pauli-Magnus, C., Hodges, L. M., Huang, C. C., Kawamoto, M., Johns, S. J., Stryke, D., Ferrin, T. E., DeYoung, J., Taylor, T., et al. (2003) · Pharmacogenetics · doi:10.1097/00008571-200308000-00006 · Cited by 429
Self-citationGene expression and molecular evolution
Akashi, H. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00250-1 · Cited by 338
Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis
Schwab, M., Schaeffeler, E., Marx, C., Fromm, M. F., Kaskas, B., Metzler, J., Stange, E., Herfarth, H., Schoelmerich, J., Gregor, M., et al. (2003) · Gastroenterology · doi:10.1053/gast.2003.50010 · Cited by 323
Cis-Acting Regulatory Variation in the Human Genome
Pastinen, T., & Hudson, T. J. (2004) · Science · doi:10.1126/science.1101659 · Cited by 265
Ho, G.-T., Nimmo, E. R., Tenesa, A., Fennell, J., Drummond, H., Mowat, C., Arnott, I. D., & Satsangi, J. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.019 · Cited by 196
Jamroziak, K., Młynarski, W., Balcerczak, E., Mistygacz, M., Treliǹska, J., Mirowski, M., Bodalski, J., & Robak, T. (2004) · European Journal of Haematology · doi:10.1111/j.1600-0609.2004.00228.x · Cited by 194
Using reliability information to annotate RNA secondary structures
ZUKER, M., & JACOBSON, A. B. (1998) · RNA · doi:10.1017/s1355838298980116 · Cited by 178
Kimchi‐Sarfaty, C., Gribar, J. J., & Gottesman, M. M. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.1.1 · Cited by 156
Functional Implications of Genetic Polymorphisms in the Multidrug Resistance Gene MDR1 (ABCB1)
Pauli-Magnus, C., & Kroetz, D. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000029276.21063.0b · Cited by 144
Self-citationLepper, E. R., Nooter, K., Verweij, J., Acharya, M. R., Figg, W. D., & Sparreboom, A. (2005) · Pharmacogenomics · doi:10.1517/14622416.6.2.115 · Cited by 142
Hitzl, M., Schaeffeler, E., Hocher, B., Slowinski, T., Halle, H., Eichelbaum, M. F., Kaufmann, P., Fritz, P., Fromm, M. F., & Schwab, M. G. (2004) · Pharmacogenetics · doi:10.1097/00008571-200405000-00006 · Cited by 137
Carlini, D. B., Chen, Y., & Stephan, W. (2001) · Genetics · doi:10.1093/genetics/159.2.623 · Cited by 125
Multidrug resistance P-glycoprotein: crucial significance in drug disposition and interaction.
Sun, J., He, Z.-G., Cheng, G., Wang, S., Hao, X.-H., & Zou, M. (2004) · PubMed · Cited by 123
Kajinami, K., Brousseau, M. E., Ordovás, J. M., & Schaefer, E. J. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.01.014 · Cited by 122
Soranzo, N., Gl, C., Weale, M. E., Wood, N. W., Depondt, C., Marguerie, R., Sisodiya, S. M., & Goldstein, D. B. (2004) · Genome Research · doi:10.1101/gr.1965304 · Cited by 118
Iida, K., & Akashi, H. D. (2000) · Gene · doi:10.1016/s0378-1119(00)00482-0 · Cited by 101
Polymorphisms affecting gene regulation and mRNA processing: Broad implications for pharmacogenetics
JOHNSON, A., WANG, D., & SADEE, W. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.11.001 · Cited by 97
Self-citationGenetic Variants of the Human H+/Dipeptide Transporter PEPT2: Analysis of Haplotype Functions
Pinsonneault, J. K., Nielsen, C. U., & Sadée, W. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.073098 · Cited by 95
Self-citationTakane, H., Kobayashi, D., Hirota, T., Kigawa, J., Terakawa, N., Otsubo, K., & Ieiri, I. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.069724 · Cited by 90
Effect of MDR1 Haplotype on Risk of Parkinson Disease
Tan, E., Chan, D. K.-Y., Ng, P.-W., Woo, J., Teo, Y., Tang, K., Wong, L.-P., Chong, S. S., Tan, C., Shen, H., et al. (2005) · Archives of Neurology · doi:10.1001/archneur.62.3.460 · Cited by 73
Owen, A., Goldring, C. E., Morgan, P., et al. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02229.x · Cited by 72
Yasui‐Furukori, N., Mihara, K., Takahata, T., et al. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2003.02061.x · Cited by 59
Calado, R. T., Falcão, R. P., Garcia, A. B., Gabellini, S. M., Zago, M. A., & Franco, R. F. (2002) · PubMed · Cited by 59
Goto, M., Masuda, S., Saito, H., & Inui, K. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00242-9 · Cited by 43
Cited by
A "Silent" Polymorphism in the MDR 1 Gene Changes Substrate Specificity
Kimchi-Sarfaty, C., Oh, J. M., Kim, I.-W., Sauna, Z. E., Calcagno, A. M., Ambudkar, S. V., & Gottesman, M. M. (2007) · Science · doi:10.1126/science.1135308 · Cited by 2,416
Synonymous but not the same: the causes and consequences of codon bias
Plotkin, J. B., & Kudla, G. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2899 · Cited by 1,685
Insecticide Resistance in Mosquitoes: Impact, Mechanisms, and Research Directions
Liu, N. (2015) · Annual Review of Entomology · doi:10.1146/annurev-ento-010814-020828 · Cited by 1,064
Common Sequence Variants in the LOXL1 Gene Confer Susceptibility to Exfoliation Glaucoma
Thorleifsson, G., Magnusson, K. P., Sulem, P., Walters, G. B., Gudbjartsson, D. F., Stefansson, H., Jonsson, T., Jonasdottir, A., Jonasdottir, A., Stefansdottir, G., et al. (2007) · Science · doi:10.1126/science.1146554 · Cited by 677
Common Sequence Variants in the LOXL1 Gene Confer Susceptibility to Exfoliation Glaucoma
Myers, J. S. (2008) · Yearbook of Ophthalmology · doi:10.1016/s0084-392x(08)79151-2 · Cited by 517
Metadata
- Authors
- Wang, D., Johnson, A. D., Papp, A. C., Kroetz, D. L., & Sadée, W.
- Venue
- Pharmacogenetics and Genomics
- Published
- 2005-10
- Volume
- 15
- Issue
- 10
- Pages
- 693-704
- ISSN
- 1744-6872 (ISSN-L)
- OpenAlex
- W2027504487
- Cited by
- 490
- References
- 32
- FWCI
- 30.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.